Login
← Go Back
Zydus Lifesciences
ZYDUSLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Pankaj R Patel · MD: Sharvil P Patel · Listing date: April 28, 2000 · Employees: 24412 · Ahmedabad · http://www.zyduscadila.com
Stock Price vs Company Growth
1d
1.6%
1w
5.6%
1m
7.7%
3m
29.8%
6m
26.3%
1y
20.5%
5y
13.9%
10y
13.4%
all
18.9%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,171 1.6%
890
1,181
Company Overview
Sales
27,148 Cr
Growth: 17.5%
Profit after Tax
5,040 Cr
Growth: 2.1%
Large Cap
1,16,838 Cr
P/E: 23.4x
Industry P/E: 33.7x
Fundamentals
Sales (Cr) ₹ 27,148
Growth 17.5%
EBITDA 27.1%
P/S 4.3x
Dividend 1.1%
P/E 23.4x
Book Value ₹ 272
PEG Ratio 1.3x
ROE 18.9%
P/B 4.2x
Shareholding Pattern
Institutions
Life Insurance Corporation Of India
3.63 %
Kotak Flexicap Fund
2.28 %
Government Pension Fund Global
1.15 %
Iepf
0.12 %
Llp
0.07 %
Promoters
Zydus Family Trust
74.86 %
Others
Increase    Decrease    No change
Company Profile Detailed
The company is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value chain of innovating (research & development), manufacturing, marketing and selling of finished dosage human formulations (generics, branded generics and specialty formulations, including biosimilars and vaccines), active pharmaceutical ingredients (APIs), animal healthcare products and consumer wellness products.
Belongs to (43 Indices) view more
Investors (136)
pankaj.r...
icici.pr...
marutham...
Followers (34)
deepak
nitin2
keerthi